Diseases
Companies
Products
Productz
Mechanisms of Action
Sites
Nippon Kayaku
>>
Phase 2
Welcome,
Profile
Billing
Logout
All trials
Active industry trials
Active owner-sponsored trials
Active trials
Export
Download options
Which format:
PDF
Excel Chart
TSV
Phase
N/A
1
2
3
4
Trials
0
2
4
6
8
10
12
14
16
18
20
Zinapar
(darinaparsin) / Solasia, Meiji Seika, Nippon Kayaku
taletrectinib
(AB-106) / Nuvation Bio
NK012
/ Nippon Kayaku
Ozarelix
(D-63153) / AEterna Zentaris, Nippon Kayaku, Assertio
